Edition:
United Kingdom

People: Mithra Pharmaceuticals SA (MITRA.BR)

MITRA.BR on Brussels Stock Exchange

27.78EUR
2:16pm BST
Change (% chg)

€-0.92 (-3.21%)
Prev Close
€28.70
Open
€28.72
Day's High
€28.78
Day's Low
€27.62
Volume
25,991
Avg. Vol
34,161
52-wk High
€36.95
52-wk Low
€18.12

Dixon, Graham 

Dr. Graham K. Dixon Ph.D. has been appointed as Chief Scientific Officer of Mithra Pharmaceuticals SA since July 16, 2019. He has a 27 year international career in the pharmaceutical industry, with a strong track record in R&D across many therapeutic areas. He also has solid leadership experience having worked across a number of R&D management positions at AstraZeneca plc and in C-level management positions in several biotech companies: Entomed SA; Galapagos NV; Addex Therapeutics SA; Sensorion SA and Onxeo SA. He has also held leadership roles in successful programmes spanning the whole continuum of R&D, including clinical proof-of-concepts and regulatory approvals. On the business side, he has held executive roles in two successful IPOs (Galapagos & Sensorion) and 10 clinical stage licensing deals. He has also held several non-executive director positions in the biotech sector and acted as an advisor to several venture capital organizations and their portfolio companies. He obtained a Bachelor's degree in Biology from the University of Bradford, UK and a PhD in Biochemistry from the University of Swansea, UK.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --